Raymond James Financial Services Advisors, Inc. Exact Sciences Corp Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 13,029 shares of EXAS stock, worth $697,442. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,029
Previous 12,571 3.64%
Holding current value
$697,442
Previous $531,000 67.04%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$42.43 - $70.83 $19,432 - $32,440
458 Added 3.64%
13,029 $887,000
Q2 2024

Jul 19, 2024
SELL
$41.33 - $74.26 $250,707 - $450,461
-6,066 Reduced 32.55%
12,571 $531,000
Q1 2024

Apr 22, 2024
BUY
$56.27 - $73.77 $43,778 - $57,393
778 Added 4.36%
18,637 $1.29 Million
Q4 2023

Jan 16, 2024
SELL
$59.06 - $75.72 $31,951 - $40,964
-541 Reduced 2.94%
17,859 $1.32 Million
Q3 2023

Oct 24, 2023
SELL
$65.94 - $99.04 $612,186 - $919,487
-9,284 Reduced 33.54%
18,400 $1.26 Million
Q2 2023

Jul 25, 2023
SELL
$62.68 - $95.05 $1.41 Million - $2.13 Million
-22,428 Reduced 44.76%
27,684 $2.6 Million
Q1 2023

Apr 14, 2023
SELL
$47.19 - $70.77 $1.66 Million - $2.49 Million
-35,164 Reduced 41.24%
50,112 $3.4 Million
Q4 2022

Feb 08, 2023
BUY
$30.35 - $53.15 $722,876 - $1.27 Million
23,818 Added 38.75%
85,276 $4.22 Million
Q3 2022

Oct 25, 2022
SELL
$31.97 - $49.37 $61,126 - $94,395
-1,912 Reduced 3.02%
61,458 $2 Million
Q2 2022

Aug 12, 2022
BUY
$35.61 - $76.23 $352,788 - $755,210
9,907 Added 18.53%
63,370 $2.5 Million
Q1 2022

May 11, 2022
BUY
$57.56 - $82.54 $328,782 - $471,468
5,712 Added 11.96%
53,463 $3.74 Million
Q4 2021

Feb 08, 2022
SELL
$72.5 - $100.68 $1.04 Million - $1.44 Million
-14,312 Reduced 23.06%
47,751 $3.72 Million
Q3 2021

Nov 02, 2021
BUY
$90.24 - $124.05 $338,941 - $465,931
3,756 Added 6.44%
62,063 $5.92 Million
Q2 2021

Aug 11, 2021
BUY
$93.66 - $139.27 $1.36 Million - $2.02 Million
14,486 Added 33.06%
58,307 $7.25 Million
Q1 2021

May 14, 2021
SELL
$116.57 - $155.01 $50,824 - $67,584
-436 Reduced 0.99%
43,821 $5.78 Million
Q4 2020

Feb 12, 2021
SELL
$99.61 - $142.12 $331,900 - $473,543
-3,332 Reduced 7.0%
44,257 $5.86 Million
Q3 2020

Nov 04, 2020
BUY
$72.92 - $102.01 $739,554 - $1.03 Million
10,142 Added 27.08%
47,589 $4.85 Million
Q2 2020

Jul 17, 2020
SELL
$55.75 - $92.75 $37,519 - $62,420
-673 Reduced 1.77%
37,447 $3.26 Million
Q1 2020

Apr 21, 2020
SELL
$37.9 - $104.44 $10,801 - $29,765
-285 Reduced 0.74%
38,120 $2.21 Million
Q4 2019

Feb 12, 2020
BUY
$77.66 - $99.74 $152,679 - $196,088
1,966 Added 5.4%
38,405 $3.55 Million
Q3 2019

Nov 07, 2019
SELL
$90.37 - $122.49 $55,216 - $74,841
-611 Reduced 1.65%
36,439 $3.29 Million
Q2 2019

Aug 06, 2019
SELL
$89.51 - $118.04 $177,677 - $234,309
-1,985 Reduced 5.09%
37,050 $4.37 Million
Q1 2019

May 06, 2019
BUY
$61.98 - $96.5 $33,593 - $52,303
542 Added 1.41%
39,035 $3.38 Million
Q4 2018

Feb 11, 2019
BUY
$56.04 - $82.66 $422,037 - $622,512
7,531 Added 24.32%
38,493 $2.43 Million
Q3 2018

Nov 14, 2018
SELL
$48.29 - $80.6 $12,072 - $20,150
-250 Reduced 0.8%
30,962 $2.44 Million
Q2 2018

Jul 30, 2018
BUY
$37.84 - $69.96 $135,013 - $249,617
3,568 Added 12.91%
31,212 $1.87 Million
Q1 2018

Apr 16, 2018
SELL
$39.82 - $57.53 $560,585 - $809,907
-14,078 Reduced 33.74%
27,644 $1.12 Million
Q4 2017

Feb 09, 2018
BUY
$46.49 - $60.51 $148,163 - $192,845
3,187 Added 8.27%
41,722 $2.19 Million
Q3 2017

Oct 26, 2017
BUY
$37.05 - $47.12 $704,468 - $895,939
19,014 Added 97.4%
38,535 $1.82 Million
Q2 2017

Aug 15, 2017
BUY
N/A
19,521
19,521 $690,000

Others Institutions Holding EXAS

# of Institutions
660
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.47B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email